Accomplishments
Houlihan Lokey's Healthcare Group 2018 Select Accomplishments
           

Houlihan Lokey’s Healthcare Group has built a reputation for providing a collaborative team-based approach that puts our client’s interests first and delivers superior outcomes in both M&A advisory and capital-raising assignments. In 2018, according to Thomson Reuters, our healthcare team was ranked the most active (No.1) in the U.S. and globally with 36 M&A deals in the U.S. and 40 globally. In fiscal year 2018, Houlihan Lokey’s Capital Markets Group raised $10 billion across more than 43 transactions.

For more information on our services or to discuss how we can help advance your vision, please contact your Houlihan Lokey representative or one of the individuals listed at the end of this message. We look forward to our continued work together.

Click each transaction for more details:


Healthcare Group Contacts

Head of the Healthcare Group
Mark Francis Managing Director MFrancis@HL.com 214.220.8484

Senior Officers
Karan Garg Managing Director KGarg@HL.com 312.456.4758
Michael Pisani Managing Director MPisani@HL.com 214.665.8611
Jon Pritti Managing Director JPritti@HL.com 212.497.7974
Matthew Ryan Managing Director MRyan@HL.com 312.456.4707
Mike Siano Director MSiano@HL.com 212.497.7956
Scott Kremeier Senior Vice President SKremeier@HL.com 312.462.6434
Trey Marinello Senior Vice President TMarinello@HL.com 312.456.4777
Andrew Redmond Senior Vice President ARedmond@HL.com 212.497.7923
Matthew Wedge Senior Vice President MWedge@HL.com 214.220.8489
Jeffrey Carsello Vice President JCarsello@HL.com 312.456.4776
Brad Hildebrand Vice President BHildebrand@HL.com 312.462.6430
Eric Weldzius Vice President EWeldzius@HL.com 312.462.6487

Capital Markets Group
Chris Dunlop Managing Director CDunlop@HL.com 212.497.4169
Anthony Martino Managing Director AMartino@HL.com 212.497.4271
Gregg Newman Managing Director GNewman@HL.com 212.497.4200
Neha Shah Director NMShah@HL.com 212.497.7949

* * * * * * *

Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia‑Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. Houlihan Lokey is ranked as the No. 1 M&A advisor for all U.S. transactions, the No. 1 global restructuring advisor, and the No. 1 global M&A fairness opinion advisor over the past 20 years, according to Thomson Reuters.
Follow us on LinkedIn Follow us

HL.com
Houlihan Lokey is a trade name for Houlihan Lokey, Inc., and its subsidiaries and affiliates, which include those in (i) the United States: Houlihan Lokey Capital, Inc., an SEC-registered broker-dealer and member of FINRA (www.finra.org) and SIPC (www.sipc.org) (investment banking services); Houlihan Lokey Financial Advisors, Inc. (financial advisory services); Houlihan Lokey Consulting, Inc. (strategic consulting services); HL Finance, LLC (syndicated leveraged finance platform); and Houlihan Lokey Real Estate Group, Inc. (real estate advisory services); (ii) Europe: Houlihan Lokey EMEA, LLP and Houlihan Lokey (Corporate Finance) Limited, authorized and regulated by the U.K. Financial Conduct Authority; Houlihan Lokey GmbH; Houlihan Lokey (Netherlands) B.V.; and Houlihan Lokey (España), S.A.; (iii) the United Arab Emirates, Dubai International Financial Centre (Dubai): Houlihan Lokey (MEA Financial Advisory) Limited, regulated by the Dubai Financial Services Authority for the provision of advising on financial products, arranging deals in investments, and arranging credit and advising on credit to professional clients only; (iv) Singapore: Houlihan Lokey (Singapore) Private Limited, an “exempt corporate finance adviser” able to provide exempt corporate finance advisory services to accredited investors only; (v) Hong Kong SAR: Houlihan Lokey (China) Limited, licensed in Hong Kong by the Securities and Futures Commission to conduct Type 1, 4, and 6 regulated activities to professional investors only; (vi) China: Houlihan Lokey Howard & Zukin Investment Consulting (Beijing) Co., Limited (financial advisory services); (vii) Japan: Houlihan Lokey K.K. (financial advisory services); and (viii) Australia: Houlihan Lokey (Australia) Pty Limited (ABN 74 601 825 227), a company incorporated in Australia and licensed by the Australian Securities and Investments Commission (AFSL number 474953) in respect of financial services provided to wholesale clients only. In the European Economic Area (EEA), Dubai, Singapore, Hong Kong, and Australia, this communication is directed to intended recipients, including actual or potential professional clients (EEA and Dubai), accredited investors (Singapore), professional investors (Hong Kong), and wholesale clients (Australia), respectively. Other persons, such as retail clients, are NOT the intended recipients of our communications or services and should not act upon this communication. This email is an advertisement from Houlihan Lokey. To opt-out from receiving marketing communications from Houlihan Lokey and to manage your preferences in relation to the communications that Houlihan Lokey sends you, click here. Written inquiries can be sent to 10250 Constellation Blvd., 5th Fl., Los Angeles, CA 90067, or you may reach us via our contact page.


CONTACT US TERMS OF USE PRIVACY